Preventing the Recurrence of Acute Pancreatitis by Alcohol and Smoking Cessation
Key facts
- Who runs it
- University of Pecs
- Where
- Hungary1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 364 people, planned
- Started
- 1 Mar 2022
- Expected to end
- 30 Jun 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Standard intervention only
- Standard intervention plus repeated intervention
- Record updated
- 26 April 2023
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Patient hospitalized with alcohol-induced AP (defined by the revised Atlanta criteria 38)
- Every day smoker (defined as an adult patient who smoked at least 100 cigarettes in his or her lifetime, and now smokes on a daily basis; as per the CDC definition), with at least 1-year history of smoking
- Aged 18-80 years
- Provided written informed consent
- Willing to participate in the intervention in every three months
Who cannot take part
- Currently taking part in a smoking cessation program
- Possible etiologies for AP other than alcohol (eg. gallstone-related, hypertriglyceridemia above 11.5 mM 40-42, hypercalcemia, viral infection) if the etiological cannot be terminated during the index admission (lack of same admission cholecystectomy, familiar hypertrygliceridemia) and cases with combined etiological factors will be excluded
- Untreated, decompensated or severe mMajor psychiatric illnesses (e.g. schizophrenia, bipolar disorder, dementia)
- Undergoing active or palliative treatment for malignancy
- Pregnancy, breastfeeding
- Life expectancy is less than two years
- Didn't agreed to participate
- Other
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Recurrence of acute pancreatitis (AP) is often facilitated by regular alcohol consumption and smoking. An applied lifestyle intervention focusing on the cessation of alcohol consumption and smoking might prevent the recurrence of AP. REAPPEAR Study is a randomized controlled trial and a cohort study focusing on the efficacy of the lifestyle intervention and the effect of quitting alcohol and smoking respectively.
The 2 groups in the trial
- Standard intervention plus repeated interventionExisting treatment, for comparison
Patients randomized to the standard intervention plus repeated intervention arm
- Standard intervention onlyExisting treatment, for comparison
Patients randomized to the standard intervention only arm
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Recurrent Acute Pancreatitis Prevention by the Elimination of Alcohol and Cigarette Smoking (REAPPEAR): Protocol of a Randomized Controlled Trial and a Cohort Study
- Fit questions
- Built from NCT04647097, who can take part
- Record updated
- 26 April 2023